APAC Esoteric Testing Market size is slated to surpass USD 16 billion by 2028, according to a latest forecast report by Graphical Research.
The rising prevalence of chronic diseases in the region has raised the demand for early disease detection using specialized diagnostic tests, including esoteric testing. According to the World Health Organization (WHO), over 77% of deaths from chronic illnesses occur in low- and middle-income countries. Some major non-communicable diseases (NCDs) highly prevalent in APAC include cardiovascular disease (CVDs), cancer, and diabetes.
Growing burden of rare diseases will act as a key driver for the market forecast. Initiation of various projects such as The Asia-Pacific Rare Diseases Network (ARDNet) Project in the region to assist in rare disease treatment is likely to positively impact industry trends.
The oncology test type segment will reach USD 3 billion by 2028. According to the WHO, nearly 10 million deaths were reported due to various types of cancer in 2020.
Several public and private organizations across the region are launching programs aimed at reducing this burden. The Chinese Anti-Cancer Association, for example, is one such non-governmental organization that undertakes systematic cancer prevention work in China.
Owing to advantages such as high sensitivity and specificity, because of an antigen-antibody reaction, the ELISA (enzyme-linked immunosorbent assay) technology segment held more than 22% share of Asia Pacific esoteric testing industry in 2021. The technology is a plate-based assay technique used for detecting substances such as antigens, antibodies, proteins, and glycoproteins in human biological samples. It can be used to diagnose HIV infection, pregnancy, and other symptoms.
An alarming increase in the prevalence of infectious and chronic diseases, such as cancer, diabetes, HIV, and hypertension, has powered ELISA technology adoption for early diagnostic testing. The global COVID-19 pandemic, for example, has increased the need for diagnostic service centers and ELISA testing to detect the virus.
Browse detailed statistical insights from the report, “Asia Pacific Esoteric Testing Market Forecast 2028 By Test type (Endocrinology, Infectious Disease & Immunology, Oncology, Toxicology, Neurology, Genomics), By Technology (Mass Spectrometry, Flow Cytometry, ELISA, Radioimmunoassay, Chemiluminescence, RT-PCR), Research Report, Country Outlook (Japan, China, India, Australia, Korea, Singapore, Malaysia), COVID-19 Impact Statistics, Price Trends, Historic Data, Growth Prospects, Competitive Industry Share” along with the table of contents (ToC) @
India esoteric testing industry is likely to see significant growth during the forecast period. One of the crucial forces anticipated to drive market outlook is the rising incidence of rare diseases. As per the Organization for Rare Diseases India (ORDI), nearly 70 million people in the nation live with a rare disease.
However, a majority of these diseases remain undiagnosed due to less awareness and the dearth of skilled healthcare professionals in the country. These factors depict that the nation offers immense growth opportunities for esoteric testing solution providers.
The APAC market for esoteric testing research report includes in-depth coverage of the industry with estimates & forecast in terms of volume in Kilotons & revenue in USD Million from 2017 to 2028, for the following segments:
Asia Pacific Market, By Test Type
- Infectious Disease & Immunology
Asia Pacific Market, By Technology
- Mass Spectrometry
- Flow Cytometry
The above information has been provided for the following countries:
- Asia Pacific